Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $1.47 is 98.65% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 1.55||$ 7.69|
|Low:||$ 1.4305||$ 0.74|
Company Description (as filed with the SEC)
We are a physician-led biopharmaceutical company focused on dermatological and immuno-inflammatory diseases. We have two commercial products and a diverse pipeline of drug candidates. Our first commercial product, ESKATA (hydrogen peroxide) topical solution, 40% (w/w), or ESKATA, is a proprietary formulation of high-concentration hydrogen peroxide topical solution which was approved by the U.S. Food and Drug Administration, or FDA, in December 2017 as an office-based prescription treatment for raised seborrheic keratosis, or SK, a common non-malignant skin tumor. We launched ESKATA in the United States in May 2018. We also submitted a Marketing Authorization Application, or MAA, for ESKATA in select countries in the European Union, Norway and Iceland in July 2017 using a decentralized procedure. ... More ...
Nasdaq Official Price
Jan. 27, 2020
Jan. 27, 2020